Login / Signup

Antifungal drug shortage in India amid an increase in invasive fungal functions during the coronavirus disease 2019 (COVID-19) pandemic.

Ashitha B ArunMohammad Mehedi HasanSudhan RackimuthuIrfan UllahTanveer MirAnwesha Saha
Published in: Infection control and hospital epidemiology (2021)
Keyphrases
  • coronavirus disease
  • candida albicans
  • respiratory syndrome coronavirus
  • adverse drug
  • cell wall
  • electronic health record